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The concept of ischemic preconditioning refers to myocar-
dial protection from ischemia-reperfusion insult by preced-
ing brief ischemic episodes (1). An extensive effort has been
made to understand the time frames and underlying mech-
anisms of ischemic preconditioning because of the potential
applicability of this phenomenon in the clinical setting,
especially because “preconditioning-mimetic” agents may
enable the development of a chronic state of tolerance to
ischemia.
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Several studies have shown that during percutaneous
transluminal balloon angioplasty (PTCA) there is amelio-
ration of the severity of the ischemic response during
repeated ischemia (2–15). In the PTCA model, the number,
duration and severity of the brief ischemic episodes and the
duration of the intervening reperfusion period can be
controlled and monitored in addition to determining the
recruitment of collateral circulation. Therefore, it is gener-
ally believed that this model resembles experimental animal
models more closely than the acute myocardial infarction,
warm-up angina and the cardiopulmonary bypass clinical
models. The PTCA model has gained popularity as a tool
for investigating the time frames and mechanisms of isch-
emic preconditioning in humans and has been used in
studies assessing the ability of various agents to mimic or
prevent preconditioning (5,15–21). In an article published
in this issue of the Journal of the American College of
Cardiology, Billinger et al. (22) used the same PTCA model
to evaluate whether adaptation to repeated brief ischemic
episodes and the protection afforded by intracoronary infu-
sion of adenosine is mediated by recruitment of collateral
flow or truly represents ischemic preconditioning. This
study adds important information to our knowledge base
regarding what happens during repetitive coronary artery
occlusions in humans.
Several aspects of the PTCA model of ischemic precon-
ditioning should be discussed, because they have relevance
to understanding and interpretation of this study.
The duration of the preconditioning stimulus. There is a
threshold for induction of protection by ischemia, including
the minimum time of each ischemic episode, the number of
episodes and the total ischemic time required to confer
protection that seems to be species dependent (23). More-
over, when the initial brief ischemic episode is too long, the
protective effect might be lost (24). In humans, repeated
balloon inflation of #1-min duration did not attenuate the
ischemic response (17,25–29). Most of the investigators, but
not all (30,31), found that 90 to 120 s of ischemia is effective
in decreasing pain and ST deviation during the subsequent
ischemia (2–6,10,15,19–21,32,33). In contrast to patients
without recruitable collaterals, in patients with good collat-
eral circulation, even two 150-s episodes of balloon inflation
did not induce preconditioning (8). Thus, not only the
duration, but the severity of ischemia, which is inversely
correlated with the magnitude of collateral recruitment, is
important in determining the protection afforded by the
preceding ischemic episode. Billinger et al. (22) used 2 min
of occlusion, which seemed to be appropriate.
Controlling for collateral recruitment. Recruitment of
collaterals is another powerful protective mechanism against
ischemia, independent of the metabolic “preconditioning
mechanisms.” In some patients, especially those with severe
preexisting coronary narrowings, collaterals can be recruited
during ischemia induced by balloon inflation and attenuate
the ischemic response (8,29,34). Therefore, it is important
to control for collateral flow, although not all studies control
for collateral circulation. In some studies, baseline collateral
circulation was assessed by coronary angiography (2,5,11,15,
20,27,28,30). However, coronary angiography only detects
collateral vessels with a diameter .100 mm (35) and
therefore, is not adequate for assessing the smaller collateral
vessels that supply the myocardium. Some of the investiga-
tors assessed coronary collaterals by myocardial contrast
echocardiography (8), flow velocity in the contralateral
artery by Doppler-tipped intra-coronary guide wire (21),
cardiac vein flow during balloon occlusion (2), or intracoro-
nary wedge pressure measured distal to the balloon catheter
(3,22). Billinger et al. used the intracoronary pressure-
derived collateral flow index, accounting for the simulta-
neous measurement of mean aortic pressure and the esti-
mate of the central venous pressure (22). One potential
limitation of the present study is that the central venous
pressure was estimated and was not directly measured. An
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optimal approach would be to document that during balloon
inflation the central venous pressure remains constant.
There is debate in the literature as to whether collaterals
can be further recruited on repeated balloon inflations.
Cribier et al. (3) described that the number of patients who
experienced pain during inflation and the intensity of pain
progressively declined with subsequent balloon inflations.
Collateral angiographic grade did not change in seven
patients and increased in 10. Coronary occlusion pressure/
mean aortic blood pressure increased in 8 patients and the
average coronary occlusion pressure for all 17 patients was
significantly higher during the fourth than the first coronary
occlusion, indicating that in some patients further recruit-
ment of collaterals can contribute to the adaptation to
repeated ischemia. Even in those patients that did not
recruit collaterals there were less angina and ST changes,
suggesting that at least in those patients preconditioning
may have been playing a role. However, others have found
that no further collateral recruitment occurs during repeated
balloon inflations (8,21). In contrast with these studies,
Billinger et al. showed that 28 out of 30 patients had an
increase in collateral flow between the first and third balloon
occlusion, indicating further collateral recruitment (22).
The surrogate end points. Of course, the end point in this
PTCA model of ischemic preconditioning or pharmaco-
logic interventions cannot be infarct size, as in the classical
model of ischemic preconditioning (1). Various surrogate
endpoints have been used, mainly subjective estimation of
the severity of pain (3–6,8,14–16,20–22,32,33), and quan-
tification of the electrocardiographic changes (8,15,16,18,
19,22,30).
Most studies have shown that the severity of pain
diminishes during repeated balloon inflations. Pharmaco-
logic interventions with preconditioning-blocking agents
such as glibenclamide (5), aminophylline (19), or bamiphyl-
line (20) prevents this adaptation. Leesar et al. reported that
adenosine, a preconditioning–mimicking agent, alleviates
pain compared with controls during the first ischemic
period (15). In contrast, Billinger et al. (22) found no
difference in chest pain score between the adenosine and
placebo pretreated patients. It should be remembered that
the severity of pain developed is dependent on several
factors in addition to the preconditioning effect, including
the duration of ischemia, recruitment of collaterals, psycho-
logical factors (the subjective perception of pain may be
higher during the first unfamiliar episode) and the degree of
stretching of the coronary artery wall by the balloon (4).
Thus, estimates of the severity of pain can only be made in
studies in which the duration of balloon inflations and the
pressure used are kept constant (4) and the collateral flow in
each ischemic episode is measured. Billinger et al. assessed
collateral recruitment during each balloon inflation and used
2 min of coronary occlusion, however, it is not clear whether
the same balloon inflation pressures were used (22). There-
fore, some degree of caution may be needed in interpreting
these data.
The magnitude of ST shift during ischemia has been used
to monitor the “severity of ischemia” and the effects of
various agents on amelioration or exacerbation of ischemia,
and has been shown to decrease during repeated coronary
occlusions (36). The magnitude of ST shift is highly
dependent on the magnitude of collateral recruitment
(8,29,36). On the other hand, reduction in the magnitude of
ST shift with repeated myocardial ischemia without recruit-
ment of collaterals has been shown in animal models (37).
However, changes in the magnitude of ST shift are not a
sine qua non for infarct size limitation, the classical end-
point of ischemic preconditioning, and caution should be
paid in using the ST shift especially when the effects of
pharmacologic agents are evaluated, because these agents
may affect the ST-T segments without an effect on myo-
cardial infarct size. For example, beta-adrenergic blocking
agents attenuate ST shift during ischemia (27,28,36); how-
ever, most clinical studies have not shown a reduction of
infarct size with beta-blockers (38).
Some investigators have used the surface electrocardio-
gram (8,11,15,30,32), others assessed the intracoronary
electrocardiogram, obtained by connecting the guide wire to
the V lead of the standard electrocardiogram (3–6,14–
16,19–21,30), as was done in the present study (22). The
intracoronary electrocardiogram is more sensitive than the
surface electrocardiogram in detecting subtle changes in the
ST amplitude during balloon inflation (15,39). It is unclear,
however, whether ischemia induced by balloon inflation in
different coronary artery segments may result in the same
magnitude of ST shift. In the present study, Billinger et al.
corrected the ST amplitude with the QRS amplitude (22).
The uncorrected ST amplitude values are not presented.
This method may correct the differences in the absolute
magnitude of ST shift among patients undergoing angio-
plasty of different coronary artery segments. However,
during PTCA there are changes in the QRS amplitude (40).
It is unclear whether they corrected the ST amplitude with
the baseline QRS or with the QRS in each evaluated
complex. Whether correction used by Billinger et al. is
superior to the common method of measuring the absolute
ST amplitude remains to be validated.
ADENOSINE AND PRECONDITIONING
IN RELATION TO THE PRESENT STUDY
There is extensive evidence supporting a prominent role for
adenosine and its receptors in mediating the cardioprotec-
tive effects of ischemic preconditioning (41,42). Bamiphyl-
line (20) and aminophylline (19), both adenosine receptor
antagonists, abolished the attenuation of the ischemic re-
sponse during repeated ischemia. On the other hand,
intracoronary application of dipyridamole, an inhibitor of
reuptake and degradation of adenosine, conferred myocar-
dial protection during PTCA (18). However, in all these
1037JACC Vol. 33, No. 4, 1999 Birnbaum and Kloner
March 15, 1999:1036–9 Editorial Comment
studies (18,19,20) collateral recruitment was not assessed;
thus the effect of ischemic preconditioning was not sepa-
rated from that of collateral recruitment. Kerensky et al.
(16) reported that the mean intracoronary ST elevation
during the first balloon inflation was comparable between
the adenosine (intracoronary 100 mg) and placebo group,
suggesting that adenosine pretreatment did not precondi-
tion the heart. The mean intracoronary ST elevation during
the second balloon inflation compared with the first infla-
tion was reduced in the placebo and increased in the
adenosine group, suggesting that adenosine might have
blocked the preconditioning effect (16). Leesar et al. (15)
used a much higher dose of adenosine (intracoronary 20 mg
infused over 10 min, starting 20 min before PTCA), and
found that the adenosine group also had less intracoronary
ST segment shift and less pain than the control group
during each of these 2-min balloon inflations. However,
although only patients with no angiographically visible
collaterals at baseline were included in this study, collateral
recruitment was not assessed (15). Therefore, it was un-
known whether the protective effect is due to collateral
recruitment, or due to metabolic “preconditioning-like”
effect. The findings of Billinger et al. in the present issue
contradict those of Leesar et al. (15). They randomized 30
patients to intracoronary saline or adenosine, using a greater
adenosine dose than Leesar (24 mg over 10 min, starting
20 min before PTCA), and found that adenosine pretreat-
ment was not associated with recruitment of collaterals or
with attenuation of the ischemic response during the first
balloon inflation (15). In contrast to Kerensky (16), but in
accordance with Leesar (15), adenosine did not prevent
further adaptation to repeated ischemia. Conversely, aden-
osine did not facilitate ischemic preconditioning, because
intracoronary ST segment shift and chest pain scores during
the second and third balloon inflations were similar between
the control and the adenosine pretreated groups. Billinger et
al. reported that the collateral flow index increased during
repeated balloon inflations in both the control and adeno-
sine groups (22). However, the correlation coefficient be-
tween the change in the ST segment shift and the change in
collateral flow index was low, indicating that the progressive
attenuation of the ischemic response could not be fully
attributed to recruitment of collaterals and that additional
factors, presumably ischemic preconditioning, are probably
more important. However, it might be that the relationship
between the ST shift and the collateral recruitment is not
linear.
There are several important differences between Leesar’s
study (15) and the present study (22). Leesar et al. included
only patients with no angiographically visible collaterals,
whereas Billinger et al. also included patients with few
collateral vessels on the first coronary angiography. Leesar et
al. used 20 mg, and Billinger et al. 24 mg, of adenosine. It
might be that at this somewhat higher dose the protective
effect of adenosine is lost, as was seen after prolonged
infusions (72 h) in the rabbit model (43). Leesar et al.
permitted use of nitrates, whereas none of the patients in
Billinger’s study received nitrates. It is unknown whether
there might be a synergistic effect between adenosine and
nitrates. Billinger et al. assessed the intracoronary ST
amplitude at 60 s of ischemia (22) and normalized it to the
QRS amplitude, whereas Leesar et al. presented the abso-
lute ST amplitudes, measured at 2 min of ischemia (15).
One minute of ischemia may not be enough, because the ST
shift is not fully evolved after 60 s. Cribier et al. showed that
at 2 min of ischemia the differences in the magnitude of the
intracoronary ST shift were more significant than those
observed at 1 min of ischemia (3). In addition, Billinger et
al. did not present how many of their patients had unstable
angina. These patients might have been already fully pre-
conditioned or in the refractory phase, as was mentioned in
the first section.
In summary, Billinger et al. showed that recruitment of
collaterals does occur during repeated balloon inflations.
This is an important observation that should be considered
in future PTCA-preconditioning protocols. However, the
recruitment of collaterals could not fully explain the adap-
tation to repeated ischemia. Ischemic preconditioning is
probably still an important mechanism for conferring adap-
tation to repeated ischemia, besides recruitment of collater-
als in these patients.
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